Environment-dependent alterations of immune mediators in urban and rural South African children with atopic dermatitis
- PMID: 34086351
- DOI: 10.1111/all.14974
Environment-dependent alterations of immune mediators in urban and rural South African children with atopic dermatitis
Abstract
Background: In order to improve targeted therapeutic approaches for children with atopic dermatitis (AD), novel insights into the molecular mechanisms and environmental exposures that differentially contribute to disease phenotypes are required. We wished to identify AD immunological endotypes in South African children from rural and urban environments.
Methods: We measured immunological, socio-economic and environmental factors in healthy children (n = 74) and children with AD (n = 78), in rural and urban settings from the same ethno-linguistic AmaXhosa background in South Africa.
Results: Circulating eosinophils, monocytes, TARC, MCP-4, IL-16 and allergen-specific IgE levels were elevated, while IL-17A and IL-23 levels were reduced, in children with AD regardless of their location. Independent of AD, children living in a rural environment had the highest levels of TNFα, TNFβ, IL-1α, IL-6, IL-8, IL-21, MCP-1, MIP-1α, MIP-1β, MDC, sICAM1, sVCAM1, VEGFA, VEGFD and Tie2, suggesting a generalized microinflammation or a pattern of trained immunity without any specific TH polarization. In contrast, IL-15, IL-22, Flt1, PIGF and βFGF were highest in urban children. Rural healthy children had the lowest levels of food allergen-specific IgG4. Early life nutritional factors, medications, animal exposures, indoor environment, sunlight exposure, household size, household income and parental education levels were associated with differences in circulating cytokine levels.
Conclusions: This study highlights the immunological impact of environmental exposures and socio-economic status in the manifestation of immune endotypes in children with AD living in urban and rural areas, which are important in selecting appropriately matched immunological therapies for treatment of AD.
Keywords: atopic dermatitis; cytokines; endotypes; environment; personalized medicine.
© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Comment in
-
Neue Stadt-Land-Daten zu Neurodermitis.MMW Fortschr Med. 2022 Jun;164(11):28-29. doi: 10.1007/s15006-022-1235-y. MMW Fortschr Med. 2022. PMID: 35650487 Review. German. No abstract available.
-
Atopic dermatitis: The importance of future research in Africa.Allergy. 2023 Jan;78(1):327-328. doi: 10.1111/all.15422. Epub 2022 Dec 5. Allergy. 2023. PMID: 36468335 No abstract available.
-
Importance of examining atopic dermatitis disease mechanisms in African populations.Allergy. 2023 Jan;78(1):329-330. doi: 10.1111/all.15559. Allergy. 2023. PMID: 36576006 No abstract available.
References
REFERENCES
-
- Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl. 1):8-16.
-
- Vakharia P, Silverberg J. New and emerging therapies for paediatric atopic dermatitis. Lancet Child Adolesc Health. 2019;3(5):343-353.
-
- Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-1122.
-
- Langan SM, Irvine AD, Weidinger S. Lancet. 2020;396(10247):345-360.
-
- Lunjani N, Hlela C, O'Mahony L. Microbiome and skin biology. Curr Opin Allergy Clin Immunol. 2019;19(4):328-333.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous